DAWN THERAPEUTICS LIMITEDActive
Key figures
Like most small UK companies, DAWN THERAPEUTICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2023/24Balance sheet structure
Filed accounts2019/20–2023/24
| 2019/20 | 2021/22 | 2023/24 | |
|---|---|---|---|
| Cash at bank and in hand | 9,519 | 924 | 14,742 |
| Total assets | 10,519 | 1,924 | 15,742 |
| Total liabilities | 35,706 | 214,359 | 550,077 |
| Net assets / total equity | -25,187 | -212,435 | -534,335 |
| Average number of employees | 1 | 1 | 1 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2024Research and experimental development on biotechnology
As described in the company's latest filed accounts.
Summary: DAWN THERAPEUTICS LIMITED
Company
DAWN THERAPEUTICS LIMITED is a private limited company registered with Companies House under company number 12312482. It was incorporated on 13 Nov 2019. Its status is active. The registered office is in London (EC2A). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2023/24 (period ending 30 Nov 2024); the company files small company accounts (filleted). Net assets were −£534,335, down 151.5% on the previous year. Cash at bank and in hand was £14,742. Total assets were £15,742 and total liabilities £550,077. The company had an average of 1 employee. Figures are available for 3 financial years (2019/20–2023/24).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Aug 2027. The next confirmation statement is due by 26 Nov 2026.